Aktis Oncology Inc
Aktis Oncology Inc (AKTS) Covered Calls
Read more
Running AKTS covered calls helps you generate income from Aktis Oncology Inc shares you already own, turning a long stock position into a yield producing asset. A covered call means holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike. Use our scanner to find the best AKTS covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call pairs limited risk with a clear income profile. If AKTS stays below the strike at expiration, you keep the premium and the shares. If it rises above, you deliver the stock at the strike and still pocket the premium. Selling AKTS covered calls works best when implied volatility is elevated, since richer premiums improve the risk reward. Key inputs include strike selection relative to delta, days to expiration, annualized return, and probability of assignment, all of which determine whether a given AKTS covered call is worth writing.
| 2026-11-20 | 7 | 17.50 | 5.29 | 0.40 | 4.90 | 128.00 | 7.70 | 401.58 | -2.41 | +0.54 | 6 | 4.50 |
| 2027-04-16 | 154 | 25.00 | 50.42 | 1.00 | 4.90 | 938.00 | 56.44 | 133.77 | -6.02 | +0.45 | 27 | 3.90 |
| 2027-01-15 | 63 | 20.00 | 20.34 | 0.10 | 4.90 | 348.00 | 20.94 | 121.31 | -0.60 | +0.47 | 1 | 4.80 |
| 2027-04-16 | 154 | 22.50 | 35.38 | 0.50 | 4.90 | 638.00 | 38.39 | 90.98 | -3.01 | +0.46 | 38 | 4.40 |
| 2027-12-17 | 399 | 30.00 | 80.51 | 2.00 | 7.00 | 1538.00 | 92.54 | 84.65 | -12.03 | +0.53 | 0 | 5.00 |
| 2027-04-16 | 154 | 20.00 | 20.34 | 1.00 | 5.50 | 438.00 | 26.35 | 62.46 | -6.02 | +0.52 | 9 | 4.50 |
| 2027-12-17 | 399 | 25.00 | 50.42 | 2.50 | 7.50 | 1088.00 | 65.46 | 59.88 | -15.04 | +0.58 | 0 | 5.00 |
| 2027-12-17 | 399 | 22.50 | 35.38 | 3.00 | 8.00 | 888.00 | 53.43 | 48.88 | -18.05 | +0.62 | 0 | 5.00 |
| 2027-01-15 | 63 | 17.50 | 5.29 | 0.50 | 4.90 | 138.00 | 8.30 | 48.11 | -3.01 | +0.54 | 1 | 4.40 |
| 2027-04-16 | 154 | 17.50 | 5.29 | 1.80 | 6.00 | 268.00 | 16.13 | 38.22 | -10.83 | +0.60 | 0 | 4.20 |
As of Nov 13, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV Rank—
- Market cap (M$)895
- 52 weeks high-52.91%
- 52 weeks low15.33%
- Analyst recommendationStrong Buy
1.00 - Target price$35.88
118.78% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-12
- P/E—
- Future P/E—
- EPS (ttm)-1.59
- EPS growth next 5 years68.26%
As of Nov 18, 2026